60 DEGREES PHARMACEUTICALS, INC. - SXTP

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2026 · Compare: Q4 2025
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Kathmere Capital Management, LLC History New 144,683 253 0.02% 1 +144,683 New Q1 2026 Apr 28, 2026
UBS Group AG History Added to 31,410 54 0.0% 2 +29,934 2028.05% Q1 2026 May 05, 2026
GEODE CAPITAL MANAGEMENT, LLC History Added to 16,295 28 0.0% 0.0% 3 +3,846 30.89% Q1 2026 May 15, 2026
BARCLAYS PLC History Added to 1,856 3 0.0% 4 +343 22.67% Q1 2026 May 14, 2026
JANE STREET GROUP, LLC History Closed out 0 0 0.0% -22,051 -100.0% Q1 2026 May 12, 2026
Tower Research Capital LLC (TRC) History Closed out 0 0 0.0% -6,738 -100.0% Q1 2026 May 15, 2026
OSAIC HOLDINGS, INC. History Reduced 25 0 -75 -75.0% Q1 2026 May 15, 2026
NewEdge Advisors, LLC History New 50 0 +50 New Q1 2026 Jun 02, 2026
BANK OF AMERICA CORP /DE/ History Closed out 0 0 -31 -100.0% Q1 2026 May 15, 2026
TWIN PEAKS WEALTH ADVISORS, LLC History New 8 0 +8 New Q1 2026 May 08, 2026
CITIGROUP INC History New 1 0 +1 New Q1 2026 May 11, 2026